Ratings by Oppenheimer (Leland Gershell)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2026 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2026 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2026 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2026 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/25/2026 | BridgeBio Pharma | BBIO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2026 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/13/2026 | BridgeBio Pharma | BBIO | Maintain | Outperform (N/A) |
|
Details | ||
| 1/13/2026 | Lexeo Therapeutics | LXEO | Maintain | Outperform (Outperform) |
|
Details | ||
| 1/6/2026 | Crinetics | CRNX | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/31/2025 | Xeris Pharmaceuticals | XERS | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/23/2025 | Spruce Biosciences, Inc. | SPRB | New Coverage | Outperform (N/A) |
82.82 (55.87) |
-32.54% | Details | |
| 12/23/2025 | Aardvark Therapeutics Inc | AARD | New Coverage | Outperform (N/A) |
14.55 (5.85) |
-59.79% | Details | |
| 12/18/2025 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 12/10/2025 | Lexeo Therapeutics | LXEO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/20/2025 | Protera Therapeutics | TARA | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/19/2025 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/12/2025 | Engene Holdings Inc. | ENGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2025 | Immunovant | IMVT | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/7/2025 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2025 | Rhythm Pharmaceuticals | RYTM | Downgrade | Perform (Outperform) |
113.74 (93.52) |
-17.78% | Details | |
| 10/31/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2025 | BridgeBio Pharma | BBIO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2025 | BridgeBio Pharma | BBIO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2025 | Tectonic Therapeutics Inc. | TECX | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/29/2025 | Xeris Pharmaceuticals | XERS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/21/2025 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/30/2025 | Climb Bio | CLYM | Maintain | Outperform (N/A) |
|
Details | ||
| 9/30/2025 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/26/2025 | Crinetics | CRNX | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/18/2025 | Avalo Therapeutics Inc. | AVTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/18/2025 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/4/2025 | Immunovant | IMVT | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/3/2025 | Tectonic Therapeutics Inc. | TECX | New Coverage | Outperform (N/A) |
16.65 (35.87) |
115.44% | Details | |
| 8/26/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/25/2025 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2025 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2025 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2025 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2025 | BridgeBio Pharma | BBIO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2025 | Alnylam Pharmaceuticals | ALNY | Upgrade | Outperform (Perform) |
401.80 (406.40) |
1.14% | Details | |
| 8/1/2025 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2025 | Lexeo Therapeutics | LXEO | New Coverage | Outperform (N/A) |
4.65 (6.85) |
47.31% | Details | |
| 7/21/2025 | SAB Biotherapeutics | SABS | Maintain | Outperform (N/A) |
|
Details | ||
| 7/10/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Outperform (N/A) |
|
Details | ||
| 7/9/2025 | BridgeBio Pharma | BBIO | Upgrade | Outperform (Perform) |
43.19 (65.36) |
51.33% | Details | |
| 6/13/2025 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/12/2025 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 6/6/2025 | Climb Bio | CLYM | New Coverage | Outperform (N/A) |
1.24 (7.18) |
479.03% | Details | |
| 6/3/2025 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/28/2025 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/16/2025 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2025 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2025 | Xeris Pharmaceuticals | XERS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (Outperform) |
|
Details | ||
| 4/21/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (Outperform) |
|
Details | ||
| 4/8/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/27/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/24/2025 | Avalo Therapeutics Inc. | AVTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/24/2025 | Quince Therapeutics Inc. | QNCX | New Coverage | Outperform (N/A) |
1.38 (0.10) |
-92.75% | Details | |
| 3/20/2025 | Immunovant | IMVT | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/7/2025 | Xeris Pharmaceuticals | XERS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2025 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2025 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2025 | BioMarin Pharmaceutical Inc. | BMRN | Upgrade | Outperform (Perform) |
68.25 (61.12) |
-10.45% | Details | |
| 2/14/2025 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 1/27/2025 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 1/24/2025 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2025 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Outperform (Outperform) |
|
Details | ||
| 1/13/2025 | Crinetics | CRNX | Maintain | Outperform (Outperform) |
|
Details | ||
| 1/13/2025 | Compugen | CGEN | New Coverage | Outperform (N/A) |
1.64 (2.08) |
26.83% | Details | |
| 1/8/2025 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/20/2024 | Rhythm Pharmaceuticals | RYTM | New Coverage | Outperform (N/A) |
55.48 (113.74) |
105.01% | Details | |
| 12/17/2024 | Viridian Therapeutic | VRDN | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/11/2024 | Spruce Biosciences, Inc. | SPRB | Downgrade | Perform (Outperform) |
0.54 (55.87) |
10246.3% | Details | |
| 11/21/2024 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/15/2024 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2024 | Dianthus Therapeutics | DNTH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2024 | Ligand Pharma | LGND | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2024 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2024 | ESSA Pharma | EPIX | Downgrade | Perform (Outperform) |
5.20 (0.20) |
-96.15% | Details | |
| 11/1/2024 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/28/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2024 | Xeris Pharmaceuticals | XERS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/16/2024 | UroGen Pharma | URGN | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/10/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Perform (Perform) |
|
Details | ||
| 10/9/2024 | Immunovant | IMVT | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2024 | Avalo Therapeutics Inc. | AVTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/8/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/1/2024 | BridgeBio Pharma | BBIO | New Coverage | Perform (N/A) |
24.80 (43.19) |
74.15% | Details | |
| 10/1/2024 | Dianthus Therapeutics | DNTH | New Coverage | Outperform (N/A) |
27.88 (65.20) |
133.86% | Details | |
| 10/1/2024 | Ligand Pharma | LGND | New Coverage | Outperform (N/A) |
101.35 (201.90) |
99.21% | Details | |
| 9/27/2024 | Engene Holdings Inc. | ENGN | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/24/2024 | Engene Holdings Inc. | ENGN | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/18/2024 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/17/2024 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 9/16/2024 | ESSA Pharma | EPIX | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/12/2024 | Protera Therapeutics | TARA | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/12/2024 | SAB Biotherapeutics | SABS | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/9/2024 | Immunovant | IMVT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/5/2024 | Ascendis Pharma | ASND | Upgrade | Outperform (Perform) |
119.50 (240.65) |
101.38% | Details | |
| 9/3/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Perform (Perform) |
|
Details | ||
| 8/28/2024 | SAB Biotherapeutics | SABS | New Coverage | Outperform (N/A) |
2.81 (3.79) |
34.88% | Details | |
| 8/28/2024 | Engene Holdings Inc. | ENGN | New Coverage | Outperform (N/A) |
6.48 (8.68) |
33.95% | Details | |
| 8/27/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2024 | Avalo Therapeutics Inc. | AVTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2024 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2024 | Protera Therapeutics | TARA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2024 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2024 | Lumos Pharma | LUMO | Maintain | Outperform (N/A) |
|
Details | ||
| 7/26/2024 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/23/2024 | argenx SE | ARGX | Upgrade | Outperform (Perform) |
461.01 (717.80) |
55.7% | Details | |
| 7/1/2024 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/14/2024 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/4/2024 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/3/2024 | Immunovant | IMVT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/15/2024 | Lumos Pharma | LUMO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2024 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2024 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/22/2024 | Protera Therapeutics | TARA | Maintain | Outperform (N/A) |
|
Details | ||
| 4/16/2024 | Avalo Therapeutics Inc. | AVTX | Upgrade | Outperform (Perform) |
15.24 (17.31) |
13.58% | Details | |
| 4/15/2024 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 3/27/2024 | Immunovant | IMVT | New Coverage | Outperform (N/A) |
31.43 (26.66) |
-15.18% | Details | |
| 3/27/2024 | Xeris Pharmaceuticals | XERS | New Coverage | Outperform (N/A) |
2.05 (5.81) |
183.41% | Details | |
| 3/20/2024 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2024 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/13/2024 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/29/2024 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2024 | Teva Pharma | TEVA | Maintain | Perform (N/A) |
|
Details | ||
| 1/24/2024 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/2/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 12/21/2023 | Catalyst Pharmaceutical Partners | CPRX | New Coverage | Outperform (N/A) |
14.73 (24.24) |
64.56% | Details | |
| 12/19/2023 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/11/2023 | Lumos Pharma | LUMO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/15/2023 | PDS Biotechnology Corp | PDSB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/14/2023 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2023 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2023 | Protera Therapeutics | TARA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/11/2023 | Alnylam Pharmaceuticals | ALNY | Downgrade | Perform (Outperform) |
169.06 (401.80) |
137.67% | Details | |
| 9/26/2023 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/15/2023 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/11/2023 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/31/2023 | Crinetics | CRNX | New Coverage | Outperform (N/A) |
16.52 (38.23) |
131.42% | Details | |
| 8/15/2023 | PDS Biotechnology Corp | PDSB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2023 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2023 | Milestone Pharmaceuticals | MIST | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2023 | Lumos Pharma | LUMO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2023 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/28/2023 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/27/2023 | Avalo Therapeutics Inc. | AVTX | Downgrade | Perform (Outperform) |
0.50 (17.31) |
3362% | Details | |
| 6/26/2023 | ESSA Pharma | EPIX | New Coverage | Outperform (N/A) |
2.90 (5.20) |
79.31% | Details | |
| 6/26/2023 | Cue Biopharma | CUE | New Coverage | Outperform (N/A) |
3.90 (0.30) |
-92.31% | Details | |
| 5/10/2023 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/12/2023 | Milestone Pharmaceuticals | MIST | Maintain | Outperform (N/A) |
|
Details | ||
| 4/4/2023 | Ascendis Pharma | ASND | Downgrade | Perform (Outperform) |
71.43 (119.50) |
67.3% | Details | |
| 3/24/2023 | X4 Pharmaceuticals | XFOR | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2023 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2023 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2023 | BioMarin Pharmaceutical Inc. | BMRN | Downgrade | Perform (Outperform) |
105.97 (61.12) |
-42.32% | Details | |
| 2/17/2023 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 2/14/2023 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 1/17/2023 | Veru, Inc. | VERU | Maintain | Outperform (Outperform) |
|
Details | ||
| 1/9/2023 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/16/2022 | Windtree Therapeutics | WINT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/15/2022 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/14/2022 | Opiant Pharma | OPNT | Downgrade | Perform (Outperform) |
9.50 (20.65) |
117.37% | Details | |
| 11/14/2022 | Fresh Tracks Therapeutics | FRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2022 | Veru, Inc. | VERU | Upgrade | Outperform (Outperform) |
15.01 (2.47) |
-83.54% | Details | |
| 11/9/2022 | Avalo Therapeutics Inc. | AVTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2022 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2022 | Horizon Therapeutics | HZNP | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2022 | BioMarin Pharmaceutical Inc. | BMRN | Upgrade | Outperform (Perform) |
86.77 (61.12) |
-29.56% | Details | |
| 10/11/2022 | argenx SE | ARGX | New Coverage | Perform (N/A) |
346.08 (461.01) |
33.21% | Details | |
| 10/4/2022 | Clene, Inc. | CLNN | Downgrade | Perform (Outperform) |
2.01 (5.36) |
166.67% | Details | |
| 9/27/2022 | Fresh Tracks Therapeutics | FRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/27/2022 | Fresh Tracks Therapeutics | FRTX | Upgrade | Outperform (Outperform) |
1.85 (0.94) |
-49.19% | Details | |
| 9/16/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/12/2022 | Horizon Therapeutics | HZNP | Maintain | Outperform (N/A) |
|
Details | ||
| 8/31/2022 | Veru, Inc. | VERU | Maintain | Outperform (Outperform) |
|
Details | ||
| 8/16/2022 | Clene, Inc. | CLNN | Maintain | Outperform (Outperform) |
|
Details | ||
| 8/16/2022 | Viridian Therapeutic | VRDN | Maintain | Outperform (Outperform) |
|
Details | ||
| 8/15/2022 | PLx Pharma | PLXP | Downgrade | Perform (Outperform) |
2.59 (0.09) |
-96.53% | Details | |
| 8/8/2022 | X4 Pharmaceuticals | XFOR | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2022 | Avalo Therapeutics Inc. | AVTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 8/4/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Perform (Perform) |
|
Details | ||
| 8/3/2022 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (Outperform) |
|
Details | ||
| 7/28/2022 | Teva Pharma | TEVA | Maintain | Perform (Perform) |
|
Details | ||
| 7/21/2022 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (Outperform) |
|
Details | ||
| 7/20/2022 | Lumos Pharma | LUMO | New Coverage | Outperform (N/A) |
7.45 (4.34) |
-41.74% | Details | |
| 7/13/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (Outperform) |
|
Details | ||
| 7/11/2022 | Veru, Inc. | VERU | Maintain | Outperform (Outperform) |
|
Details | ||
| 7/8/2022 | Horizon Therapeutics | HZNP | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/27/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Perform (Perform) |
|
Details | ||
| 6/22/2022 | Acasti Pharma | ACST | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/9/2022 | Veru, Inc. | VERU | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/8/2022 | PDS Biotechnology Corp | PDSB | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/7/2022 | VBI Vaccines | VBIV | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/6/2022 | Horizon Therapeutics | HZNP | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/2/2022 | Clene, Inc. | CLNN | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/23/2022 | Veru, Inc. | VERU | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/19/2022 | Avalo Therapeutics Inc. | AVTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/17/2022 | PLx Pharma | PLXP | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/13/2022 | Brickell Biotech Inc. | BBI | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/13/2022 | Veru, Inc. | VERU | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/13/2022 | Milestone Pharmaceuticals | MIST | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/13/2022 | X4 Pharmaceuticals | XFOR | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/13/2022 | CASI Pharmaceuticals | CASI | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/13/2022 | Viridian Therapeutic | VRDN | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/12/2022 | PDS Biotechnology Corp | PDSB | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/11/2022 | Opiant Pharma | OPNT | Maintain | Outperform (N/A) |
|
Details | ||
| 4/28/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Perform (Perform) |
|
Details | ||
| 4/26/2022 | UroGen Pharma | URGN | Maintain | Outperform (Outperform) |
|
Details | ||
| 4/25/2022 | Milestone Pharmaceuticals | MIST | Maintain | Outperform (N/A) |
|
Details | ||
| 4/12/2022 | Veru, Inc. | VERU | Maintain | Outperform (Outperform) |
|
Details | ||
| 4/12/2022 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 4/5/2022 | Clene, Inc. | CLNN | Maintain | Outperform (Outperform) |
|
Details | ||
| 4/4/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (Outperform) |
|
Details | ||
| 4/4/2022 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/31/2022 | Agile Therapeutics | AGRX | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/29/2022 | CASI Pharmaceuticals | CASI | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/21/2022 | X4 Pharmaceuticals | XFOR | Maintain | Outperform (N/A) |
|
Details | ||
| 3/21/2022 | Baudax Bio Inc. | BXRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/16/2022 | Brickell Biotech Inc. | BBI | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/16/2022 | Opiant Pharma | OPNT | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/15/2022 | Horizon Therapeutics | HZNP | New Coverage | Outperform (N/A) |
100.76 (116.30) |
15.42% | Details | |
| 3/14/2022 | Protera Therapeutics | TARA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/14/2022 | Viridian Therapeutic | VRDN | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/14/2022 | PLx Pharma | PLXP | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2022 | Ascendis Pharma | ASND | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/28/2022 | VBI Vaccines | VBIV | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/24/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Perform (Perform) |
|
Details | ||
| 2/15/2022 | Acasti Pharma | ACST | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/15/2022 | Clene, Inc. | CLNN | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/14/2022 | Opiant Pharma | OPNT | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/14/2022 | Ascendis Pharma | ASND | Upgrade | Outperform (Perform) |
122.84 (240.65) |
95.91% | Details | |
| 2/11/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/10/2022 | Teva Pharma | TEVA | Maintain | Perform (Perform) |
|
Details | ||
| 2/9/2022 | Veru, Inc. | VERU | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/9/2022 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 2/3/2022 | PDS Biotechnology Corp | PDSB | Maintain | Outperform (Outperform) |
|
Details | ||
| 1/21/2022 | Veru, Inc. | VERU | Maintain | Outperform (Outperform) |
|
Details | ||
| 1/12/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/27/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 12/22/2021 | Acasti Pharma | ACST | New Coverage | Outperform (N/A) |
1.12 (3.37) |
200.89% | Details | |
| 12/9/2021 | Opiant Pharma | OPNT | New Coverage | Outperform (N/A) |
29.94 (20.65) |
-31.03% | Details | |
| 11/16/2021 | Corbus Pharmaceuticals | CRBP | Maintain | Perform (N/A) |
|
Details | ||
| 11/10/2021 | Avalo Therapeutics Inc. | AVTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2021 | Protera Therapeutics | TARA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/1/2021 | Alnylam Pharmaceuticals | ALNY | Upgrade | Outperform (Perform) |
159.56 (320.66) |
100.97% | Details | |
| 10/28/2021 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Perform (N/A) |
|
Details | ||
| 9/28/2021 | Clene, Inc. | CLNN | New Coverage | Outperform (N/A) |
7.18 (2.01) |
-72.01% | Details | |
| 9/20/2021 | Clarus | CRXT | New Coverage | Outperform (N/A) |
8.81 (0.10) |
-98.86% | Details | |
| 8/27/2021 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2021 | CASI Pharmaceuticals | CASI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2021 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2021 | Milestone Pharmaceuticals | MIST | Maintain | Outperform (N/A) |
|
Details | ||
| 7/22/2021 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/15/2021 | PLx Pharma | PLXP | Maintain | Outperform (N/A) |
|
Details | ||
| 6/9/2021 | PDS Biotechnology Corp | PDSB | Maintain | Outperform (N/A) |
|
Details | ||
| 6/4/2021 | Windtree Therapeutics | WINT | New Coverage | Outperform (N/A) |
1.98 (0.11) |
-94.44% | Details | |
| 5/24/2021 | Cerecor | CERC | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2021 | Baudax Bio Inc. | BXRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2021 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/9/2021 | PLx Pharma | PLXP | New Coverage | Outperform (N/A) |
9.00 (0.09) |
-99% | Details | |
| 3/31/2021 | Milestone Pharmaceuticals | MIST | Maintain | Outperform (N/A) |
|
Details | ||
| 3/30/2021 | Ascendis Pharma | ASND | Downgrade | Perform (Outperform) |
128.86 (240.65) |
86.75% | Details | |
| 3/26/2021 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2021 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2021 | PDS Biotechnology Corp | PDSB | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2021 | Trevena | TRVN | New Coverage | Perform (N/A) |
2.16 (2.50) |
15.74% | Details | |
| 2/26/2021 | Acceleron Pharma | XLRN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2021 | Protera Therapeutics | TARA | New Coverage | Outperform (N/A) |
20.88 (5.90) |
-71.74% | Details | |
| 2/17/2021 | Baudax Bio Inc. | BXRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/12/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Perform (N/A) |
|
Details | ||
| 2/11/2021 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 12/31/2020 | miRagen Therapeutics | MGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/17/2020 | Avenue Therapeutics | ATXI | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2020 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2020 | Teva Pharma | TEVA | New Coverage | Perform (N/A) |
9.61 (31.05) |
223.1% | Details | |
| 11/18/2020 | Cerecor | CERC | Maintain | Outperform (N/A) |
|
Details | ||
| 11/16/2020 | Acceleron Pharma | XLRN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2020 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2020 | ADMA Biologics | ADMA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2020 | CASI Pharmaceuticals | CASI | New Coverage | Outperform (N/A) |
1.60 (0.21) |
-86.88% | Details | |
| 10/21/2020 | Baudax Bio Inc. | BXRX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/8/2020 | Corbus Pharmaceuticals | CRBP | Downgrade | Perform (Outperform) |
9.25 (8.01) |
-13.41% | Details | |
| 9/1/2020 | Acasti Pharma | ACST | Downgrade | Perform (Outperform) |
0.71 (3.37) |
374.65% | Details | |
| 8/28/2020 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 8/28/2020 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 8/25/2020 | Brickell Biotech Inc. | BBI | New Coverage | Outperform (N/A) |
0.80 (2.35) |
193.75% | Details | |
| 8/14/2020 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2020 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2020 | Baudax Bio Inc. | BXRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2020 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2020 | Alnylam Pharmaceuticals | ALNY | Downgrade | Perform (Outperform) |
138.57 (320.66) |
131.41% | Details | |
| 8/10/2020 | Evofem Biosciences Inc | EVFM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Perform (N/A) |
|
Details | ||
| 7/29/2020 | Milestone Pharmaceuticals | MIST | Upgrade | Outperform (Perform) |
8.01 (1.58) |
-80.27% | Details | |
| 6/25/2020 | Acceleron Pharma | XLRN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/23/2020 | VBI Vaccines | VBIV | Maintain | Outperform (N/A) |
|
Details | ||
| 6/18/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Perform (N/A) |
|
Details | ||
| 6/9/2020 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 6/8/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/27/2020 | Evofem Biosciences Inc | EVFM | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/27/2020 | Cerecor | CERC | Maintain | Outperform (N/A) |
|
Details | ||
| 5/20/2020 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 5/12/2020 | Recro Pharma | REPH | Maintain | Outperform (N/A) |
|
Details | ||
| 5/12/2020 | Acceleron Pharma | XLRN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2020 | Baudax Bio Inc. | BXRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2020 | Epizyme | EPZM | Maintain | Perform (N/A) |
|
Details | ||
| 4/20/2020 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 4/17/2020 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/6/2020 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/6/2020 | Acceleron Pharma | XLRN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/1/2020 | Epizyme | EPZM | Downgrade | Perform (Outperform) |
15.51 (1.47) |
-90.52% | Details | |
| 3/31/2020 | Avenue Therapeutics | ATXI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/31/2020 | Amarin Corporation | AMRN | Upgrade | Perform (Outperform) |
13.58 (14.06) |
3.53% | Details | |
| 3/25/2020 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/24/2020 | Milestone Pharmaceuticals | MIST | Downgrade | Perform (Outperform) |
14.00 (8.01) |
-42.79% | Details | |
| 3/20/2020 | Ascendis Pharma | ASND | New Coverage | Outperform (N/A) |
98.40 (240.65) |
144.56% | Details | |
| 3/5/2020 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2020 | Recro Pharma | REPH | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2020 | Recro Pharma | REPH | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2020 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2020 | Acceleron Pharma | XLRN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2020 | Amarin Corporation | AMRN | Maintain | Underperform (N/A) |
|
Details | ||
| 2/21/2020 | Baudax Bio Inc. | BXRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2020 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/13/2020 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 2/12/2020 | Amarin Corporation | AMRN | Maintain | Underperform (N/A) |
|
Details | ||
| 2/11/2020 | Acceleron Pharma | XLRN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 1/31/2020 | miRagen Therapeutics | MGEN | Maintain | Perform (N/A) |
|
Details | ||
| 1/29/2020 | Outlook Therapeutics Incs. | OTLK | Maintain | Outperform (N/A) |
|
Details | ||
| 1/28/2020 | Acceleron Pharma | XLRN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/22/2020 | Amarin Corporation | AMRN | Maintain | Underperform (N/A) |
|
Details | ||
| 1/21/2020 | Baudax Bio Inc. | BXRX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/13/2020 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/10/2020 | Cerecor | CERC | New Coverage | Outperform (N/A) |
4.67 (2.93) |
-37.26% | Details | |
| 1/7/2020 | Amarin Corporation | AMRN | Maintain | Underperform (N/A) |
|
Details | ||
| 12/26/2019 | Acasti Pharma | ACST | Maintain | Outperform (N/A) |
|
Details | ||
| 12/23/2019 | X4 Pharmaceuticals | XFOR | New Coverage | Outperform (N/A) |
10.40 (3.76) |
-63.85% | Details | |
| 12/23/2019 | Soleno Therapeutics Inc. | SLNO | New Coverage | Outperform (N/A) |
1.73 (39.68) |
2193.64% | Details | |
| 12/17/2019 | miRagen Therapeutics | MGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2019 | Amarin Corporation | AMRN | Maintain | Underperform (N/A) |
|
Details | ||
| 12/3/2019 | Evofem Biosciences Inc | EVFM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/3/2019 | Evofem Biosciences Inc | EVFM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/26/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/20/2019 | Amarin Corporation | AMRN | New Coverage | Underperform (N/A) |
22.60 (13.58) |
-39.91% | Details | |
| 11/20/2019 | Alnylam Pharmaceuticals | ALNY | New Coverage | Outperform (N/A) |
92.73 (320.66) |
245.8% | Details | |
| 11/18/2019 | Anchiano Therapeutics | ANCN | Downgrade | Perform (Outperform) |
1.92 (4.71) |
145.31% | Details | |
| 11/14/2019 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2019 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2019 | Acceleron Pharma | XLRN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2019 | Recro Pharma | REPH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2019 | Acceleron Pharma | XLRN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2019 | Epizyme | EPZM | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2019 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2019 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2019 | Epizyme | EPZM | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2019 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2019 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2019 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2019 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/24/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Perform (N/A) |
|
Details | ||
| 9/17/2019 | Acceleron Pharma | XLRN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2019 | Recro Pharma | REPH | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Perform (N/A) |
|
Details | ||
| 7/18/2019 | Acasti Pharma | ACST | New Coverage | Outperform (N/A) |
1.40 (3.37) |
140.71% | Details | |
| 6/25/2019 | ADMA Biologics | ADMA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/19/2019 | VBI Vaccines | VBIV | Maintain | Outperform (N/A) |
|
Details | ||
| 6/14/2019 | Veru, Inc. | VERU | Maintain | Outperform (N/A) |
|
Details | ||
| 6/6/2019 | Agile Therapeutics | AGRX | New Coverage | Outperform (N/A) |
1.11 (1.51) |
36.04% | Details | |
| 6/4/2019 | Milestone Pharmaceuticals | MIST | New Coverage | Perform (N/A) |
20.70 (14.00) |
-32.37% | Details | |
| 5/16/2019 | Outlook Therapeutics Incs. | OTLK | New Coverage | Outperform (N/A) |
1.03 (0.41) |
-60.19% | Details | |
| 4/26/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Perform (N/A) |
|
Details | ||
| 4/22/2019 | Acceleron Pharma | XLRN | New Coverage | Outperform (N/A) |
39.69 (178.75) |
350.37% | Details | |
| 4/12/2019 | Evofem Biosciences Inc | EVFM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/4/2019 | Recro Pharma | REPH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/2/2019 | ADMA Biologics | ADMA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2019 | Recro Pharma | REPH | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/21/2019 | miRagen Therapeutics | MGEN | New Coverage | Outperform (N/A) |
3.32 (23.01) |
593.07% | Details | |
| 3/20/2019 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2019 | Veru, Inc. | VERU | New Coverage | Outperform (N/A) |
1.49 (15.01) |
907.38% | Details | |
| 3/19/2019 | Corbus Pharmaceuticals | CRBP | New Coverage | Outperform (N/A) |
6.70 (9.25) |
38.06% | Details | |
| 3/11/2019 | Anchiano Therapeutics | ANCN | New Coverage | Outperform (N/A) |
7.84 (1.92) |
-75.51% | Details | |
| 2/28/2019 | UroGen Pharma | URGN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2019 | Epizyme | EPZM | New Coverage | Outperform (N/A) |
13.76 (1.47) |
-89.32% | Details | |
| 2/27/2019 | MEI Pharma | MEIP | New Coverage | Outperform (N/A) |
2.80 (3.07) |
9.64% | Details | |
| 2/26/2019 | AzurRx Biopharma | AZRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Perform (Perform) |
|
Details | ||
| 2/13/2019 | ADMA Biologics | ADMA | Maintain | Outperform (N/A) |
|
Details | ||
| 1/16/2019 | VBI Vaccines | VBIV | New Coverage | Outperform (N/A) |
1.80 (0.07) |
-96.11% | Details | |
| 12/18/2018 | Catalyst Pharmaceutical Partners | CPRX | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/14/2018 | BioMarin Pharmaceutical Inc. | BMRN | New Coverage | Perform (N/A) |
94.51 (61.12) |
-35.33% | Details | |
| 11/15/2018 | Avenue Therapeutics | ATXI | Maintain | Outperform (N/A) |
|
Details | ||
| 10/17/2018 | AzurRx Biopharma | AZRX | New Coverage | Outperform (N/A) |
2.50 (3.45) |
38% | Details | |
| 10/10/2018 | AcelRx Pharmaceuticals | ACRX | Maintain | Perform (N/A) |
|
Details | ||
| 9/4/2018 | Vaccinex | VCNX | New Coverage | Outperform (N/A) |
9.99 (1.41) |
-85.89% | Details |
